Detour2 Continued Access Study

Clinical trial NCT04625660 · COMPLETED

Trial details

NCT number: NCT04625660
Sponsor: Endologix
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Peripheral Artery Diseases

Start date: 2021-04-07
Primary completion: 2024-05-14
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.